Daniela Cardinale, MD, PhD discusses her career as a cardio-oncologist and reviews the role of biomarkers in the field of cardio-oncology. Moderated by Sarah Waliany, MD, MS.
Michael Fradley, MD, and Naveen Pemmaraju, MD, provide overview of treatment landscape of chronic myeloid leukemia, review cardiovascular toxicities of BCR-ABL TKIs, and discuss role of social media in cardio-oncology. Moderated by Sarah Waliany, MD, MS.
Joseph R. Carver, MD and Tochukwu (Tochi) Okwuosa, DO, discuss how to develop educational collaborations in the field of cardio-oncology. Moderated by Sarah Waliany, MD, MS.
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides and Dr. Brian Olshansky
Commentary by Drs. Sadeer Al-Kindi and Dhanunjaya Lakkireddy
Commentary by Dr. Colleen Clancy
Commentary by Drs. Pratik Doshi, Robert Roswell and Michael Solomon discussing the growth of the field, and the need for cardiologists with a strong foundation in critical medicine to provide quality care for some of our sickest patients.
Commentary by Dr. Julia Grapsa